Holen Sie sich die Stockscreener-App
2.614
7.99%
-0.266
Handel nachbörslich:
2.61
-0.004
-0.15%
Schlusskurs vom Vortag:
$2.88
Offen:
$2.7151
24-Stunden-Volumen:
1,389
Relative Volume:
0.18
Marktkapitalisierung:
$1.69M
Einnahmen:
$17.86M
Nettoeinkommen (Verlust:
$-3.67M
KGV:
-0.258
EPS:
-10.1315
Netto-Cashflow:
$-5.40M
1W Leistung:
+4.33%
1M Leistung:
-19.21%
6M Leistung:
-28.95%
1J Leistung:
-43.25%
1-Tages-Spanne:
$2.59
$2.7151
1-Wochen-Bereich:
$2.51
$2.9093
52-Wochen-Spanne:
$2.00
$11.00
Universe Pharmaceuticals Inc Stock (UPC) Company Profile
Compare UPC vs TAK, HLN, TEVA, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
UPC
Universe Pharmaceuticals Inc
|
2.614 | 1.87M | 17.86M | -3.67M | -5.40M | -10.13 |
TAK
Takeda Pharmaceutical Co Adr
|
15.87 | 51.34B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.24 | 41.15B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.63 | 39.67B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
80.24 | 34.09B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
578.43 | 24.13B | 3.17B | 1.29B | 1.01B | 27.09 |
Universe Pharmaceuticals Inc Aktie (UPC) Neueste Nachrichten
Universe Pharmaceuticals (UPC) Surges 8%: Key Support and Resistance Levels to WatchCatalyst Driven Stocks - Newser
Gang Lai Discloses Stake at Universe Pharmaceuticals with 13.58% Holding - TradingView
Universe Pharmaceuticals (NASDAQ: UPC) CEO receives share grants under 2026 equity plan - Stock Titan
Universe Pharmaceuticals (NASDAQ: UPC) CEO Gang Lai reports 13.58% ownership in Schedule 13D - Stock Titan
Universe Pharmaceuticals Grants CEO Majority-Strengthening Equity Award Under 2026 Plan - TipRanks
UPC Stock Price, Quote & Chart | UNIVERSE PHARMACEUTICAL-CL A (NASDAQ:UPC) - ChartMill
Universe Pharmaceuticals (NASDAQ: UPC) CEO now holds 75% voting power - Stock Titan
TradingKey - TradingKey
UPC (Universe) points to strong generic drug sales momentum as key driver of its latest quarterly results.Subscription Growth - newser.com
Universe Pharmaceuticals Adopts 2026 Equity Incentive Plan to Align Talent and Shareholder Interests - TipRanks
Universe Colorbond Fencing Brisbane expands services - openPR.com
12 Health Care Stocks Moving In Thursday's After-Market SessionAdvanced Biomed (NASDAQ:ADVB), BNB Plus - Benzinga
Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B - MSN
Mattel’s Masters Of The Universe Diner Tour Highlights Brand And Valuation Story - Yahoo Finance
Jiawen Pang Net Worth (2026) - GuruFocus
Ding Zheng Net Worth (2026) - GuruFocus
Lin (lydia) Yang Net Worth (2026) - GuruFocus
Baochang Liu Net Worth (2026) - GuruFocus
Yongping Yu Net Worth (2026) - GuruFocus
Gang Lai Net Worth (2026) - GuruFocus
Form 6-KReport of foreign issuer [Rules 13a-16 and 15d-16] - ADVFN
Universe Pharmaceuticals (UPC) sets 2026 equity incentive plan with 84,500 shares - Stock Titan
Will Clearside Biomedical Inc benefit from geopolitical trendsMarket Sentiment Summary & Daily Stock Trend Reports - baoquankhu1.vn
SGN PE Ratio & Valuation, Is SGN Overvalued - Intellectia AI
Market Outlook: Is TOMZ part of any major index2026 Trade Ideas & Long-Term Investment Growth Plans - baoquankhu1.vn
Aug Momentum: Can Universe Pharmaceuticals INC be the next market leader2026 Big Picture & Community Supported Trade Ideas - baoquankhu1.vn
SGN Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure - Yahoo Finance
CDT PE Ratio & Valuation, Is CDT Overvalued - Intellectia AI
PRFX PE Ratio & Valuation, Is PRFX Overvalued - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
Universe Pharmaceuticals Inc (UPC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
UPC Tests Support: Bearish Momentum Builds - Newser
UPC Should I Buy - Intellectia AI
CNSP PE Ratio & Valuation, Is CNSP Overvalued - Intellectia AI
Retail Surge: How Universe Pharmaceuticals INC stock compares to market leaders2026 Movers & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
EZGO PE Ratio & Valuation, Is EZGO Overvalued - Intellectia AI
UPC SEC FilingsUniverse Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Sell Signal: Should you avoid WTBA stock right now2026 Bull vs Bear & Real-Time Price Movement Reports - baoquankhu1.vn
Iterum Therapeutics PLC (ITRM) Stock Price, Quote, News & History - Benzinga
Chipmakers Recap: Is Addex Therapeutics Ltd Depositary Receipt stock a falling knife or bargain buyQuarterly Trade Review & Consistent Return Investment Signals - baoquankhu1.vn
Investor Mood: Is VLGEA benefiting from interest rate changes2026 Rallies & Reliable Trade Execution Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Portfolio Shifts: Should I invest in Universe Pharmaceuticals INC before earnings2026 Recap & Accurate Intraday Trade Tips - baoquankhu1.vn
Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B (XLV:NYSEARCA) - Seeking Alpha
Mattel Unveils Full "Masters of the Universe" Product Line Ahead of Highly Anticipated Live-Action Film - Yahoo Finance
China SXT Pharmaceuticals, Inc. Announces Share Re-classification - Yahoo Finance
If You Invested $1,000 in AKANDA CORP (AKAN) - Stock Titan
Universe Pharmaceuticals (NASDAQ: UPC) director Zheng Ding files Form 3 - Stock Titan
Universe Pharmaceuticals (UPC) CEO lists 3,467 Class B shares - Stock Titan
Finanzdaten der Universe Pharmaceuticals Inc-Aktie (UPC)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.13%
6.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):